Valsartan improved myocardial fibrosis and diastolic dysfunction in hypertensive patients, preferentially in patients with severe fibrosis

被引：0
|
作者：
Mizuta, Yoshihiko [1 ]
Kai, Hisashi [1 ]
Mizoguchi, Minori [1 ]
Tahara, Nobuhiro [1 ]
Osada, Katsunori [1 ]
Imaizumi, Tsutomu [1 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan
来源：
HYPERTENSION | 2008年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E78 / E78
页数：1
相关论文
共 50 条
  • [41] Biomarkers in patients with myocardial fibrosis
    An, Zhe
    Yang, Guang
    Zheng, Haikuo
    Nie, Wei
    Liu, Guohui
    OPEN LIFE SCIENCES, 2017, 12 (01): : 337 - 344
  • [42] Assessment of the relationships between left ventricular filling pressures and longitudinal dysfunction with myocardial fibrosis in uncomplicated hypertensive patients
    Contaldi, Carla
    Imbriaco, Massimo
    Alcidi, Gianmarco
    Ponsiglione, Andrea
    Santoro, Ciro
    Puglia, Marta
    Barbuto, Luigi
    Cuocolo, Alberto
    Trimarco, Bruno
    Galderisi, Maurizio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 84 - 86
  • [43] Tandospirone enhances the anti-myocardial fibrosis effect of valsartan in spontaneously hypertensive rats
    Huang, Xuefei
    Kang, Yaqi
    Jiang, Xinrui
    Yang, Jing
    Wu, An-Guo
    Zhang, Chuanqing
    Qin, Dalian
    Cao, Shousong
    Mei, Qibin
    Ye, Yun
    Wu, Jianming
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 126
  • [44] Exercise testing in hypertensive patients with diastolic dysfunction
    Pek, B
    Macle, L
    Larivée, P
    Lepage, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A413 - A413
  • [45] The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive rats
    Liu, Yihai
    Zhong, Chongxia
    Si, Jiayi
    Chen, Shan
    Kang, Lina
    Xu, Biao
    JOURNAL OF HYPERTENSION, 2022, 40 (09) : 1822 - 1830
  • [46] MYOCARDIAL DISARRAY AND FIBROSIS MAY CAUSE LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION DURING EXERCISE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    ISHIJIMA, M
    MORI, H
    MATSUOKA, H
    UTSUNOMIYA, T
    KURIYA, T
    OKU, Y
    YANO, K
    CIRCULATION, 1992, 86 (04) : 593 - 593
  • [47] Mid-myocardial fibrosis by cardiac magnetic resonance in patients with lamin A/C cardiomyopathy: Possible substrate for diastolic dysfunction
    Raman, Subha V.
    Sparks, Elizabeth A.
    Baker, Peter M.
    McCarthy, Beth
    Wooley, Charles F.
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2007, 9 (06) : 907 - 913
  • [48] RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSIVE PATIENTS
    Zacharopoulou, I.
    Tsoukas, A.
    Kallistratos, M. S.
    Poulimenos, L. E.
    Kouremenos, N.
    Karamanou, A.
    Chamodraka, E.
    Vrakas, S.
    Kontogianis, N.
    Martineos, A.
    Tsoukanas, K.
    Pagoni, S.
    Kyfnidis, K.
    Manolis, A. J.
    JOURNAL OF HYPERTENSION, 2015, 33 : E330 - E330
  • [49] Diastolic dysfunction in patient with cystic fibrosis
    Koelling, TM
    Ginns, LC
    Khaw, KT
    Systrom, DM
    Dec, GW
    DiSalvo, TG
    Semigran, MJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 7162 - 7162
  • [50] Cardiac Fibrosis as a Cause of Diastolic Dysfunction
    Brad S. Burlew
    Karl T. Weber
    Herz, 2002, 27 : 92 - 98
12345